Moderna Therapeutics, a clinical-stage biotechnology firm that develops messenger RNA (mRNA) therapeutics and vaccines, has secured $500 million in a round participated by Singapore-based EDBI and Sequoia Capital China, it announced in a release.
EDBI backs $500m Series G investment in biotech firm Moderna Therapeutics
Bring stories like this into your inbox every day.
Sign up for our newsletter - The Daily Brief
Join DealstreetAsia's Premium subscription service
Unlock your competitive advantage in rapidly evolving cape. Our packages come with exclusive access to archive content, data, discount on summit tickets & more Be a part of our growing community now.